J. WOOD CAPITAL ADVISORS LLC - 14 Oct 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: J. WOOD CAPITAL ADVISORS LLC
Reporting Manager: J. Wood Capital Advisors LLC
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 20,054,269 shares
Disclosed Ownership: 1,000,708 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 03 Nov 2025, 16:30:16 UTC
Date of event: 14 Oct 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
J. Wood Capital Advisors LLC	5%	1,000,708	0	1,000,708	/s/ Jason Wood	Jason Wood, Chief Executive Officer
Jason Wood	5%	1,000,708	0	1,000,708	/s/ Jason Wood	Jason Wood